Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    New Treatment Strategy Improves Depression in Patients With Cancer - (DGNews)
    TopAbstracts in Depression 07/02/2008 - (DGNews)
    TopAbstracts in Depression 06/25/2008 - (DGNews)
    TopAbstracts in Depression 06/18/2008 - (DGNews)
    Pregabalin Effective for Fibromyalgia Pain Regardless of Patient Anxiety or Depression: Presented at EULAR - (DGDispatch)

    News archive

     Recent webcasts/CME - Depression
    • Understanding and Managing the Fibromyalgia Syndrome
    • Accurate Diagnosis of Fibromyalgia Is Essential for Effective Management
    • Recognition and Management of Depression
      Understanding the Vital Link: Depression and Chronic Disease
      Female Sexual Dysfunction and Depression: Addressing Cause and Effect

      Webcasts/CME archive

       Recent cases - Depression
        Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report
        Dissecting the Determinants of Depressive Disorders Outcome: An in Depth Analysis of Two Clinical Cases
        Incomplete Oedipism and Chronic Suicidality in Psychotic Depression with Paranoid Delusions Related to Eyes
        Excessive Weight Gain after Remission of Depression in a Schizophrenic Patient Treated with Risperidone: Case Report
        Fluoxetine Withdrawal Syndrome in the Newborn

        Cases archive
          




        my personal edition > depression > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Continuation of Antidepressant Treatment Beneficial for Some Patients With Bipolar Disorder

        A DGReview of :"A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network"
        Bipolar Disorders

        12/09/2003
        By Emma Hitt, PhD


        In bipolar patients who remain well on antidepressants for at least 2 months, treatment should be continued, as discontinuation can increase the risk of depression relapse without preventing mania, researchers write.

        Considerable controversy continues to persist regarding the use of unimodal antidepressants in combination with mood stabilisers for the treatment of bipolar depression.

        Robert M. Post, MD, National Institute of Mental Health, Biological Psychiatry Branch, Bethesda, Maryland, United States, and colleagues reviewed three new studies to evaluate the rate of depression in bipolar illness, switch rates on antidepressants, and risks of antidepressant discontinuation.

        In the first study reviewed, 258 outpatients with bipolar illness were assessed prospectively on a daily basis for 1 year using the National Institute of Mental Health-Life Chart Method (NIMH-LCM). These patients showed three times as many days depressed as days manic, re-emphasizing the considerable depressive morbidity that exists in bipolar disorder.

        In the second study, 127 bipolar depressed patients were randomised to receive 10 weeks of sertraline, bupropion or venlafaxine as adjuncts to mood stabilisers. Patients who did not respond were re-randomised and responders were offered a year of continued antidepressant therapy.

        Acute augmentation of antidepressant dose was associated with a modest response rate, with 18.2% switched from a hypomanic to a manic episode, and 35.6% of the patients on continuation trials showed these two types of switches.

        In the third study, the risk of depressive relapses in patients who remained on antidepressants after 2 months of euthymia compared with those who discontinued treatment were retrospectively and prospectively assessed.

        Those who remained well on any antidepressant for more than 2 months (15-20% of those initially treated) and who continued on these drugs showed a lesser rate of relapse into depression over 1 year (35% and 36% in the first and second study, respectively) compared with those who discontinued their antidepressant (68% and 70% relapsing into depression).

        "One is reluctant to make a formal schematic or treatment algorithm for patients with breakthrough bipolar depression in light of the rapidly changing perspectives," Dr. Post and colleagues note. However, in their report, they provide a table of "soft recommendations" suggesting treatment for breakthrough depression with mood stabiliser use.
        Bipolar Disord 2003 Dec;5:6:396-406. "A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send